ESTRO PT 2018

A phase I/II clinical trial of carbon ion radiotherapy and concurrent gemcitabine chemotherapy for patients with preoperative pancreatic cancer

Schema for New Protocol

Pretreatment Staging Evaluation

CIRT （ 36.8GyE/8fr ） + GEM(1000mg/m 2 ) × 3

IC

Ope

End

Follow-up

HIMAC 36.8GyE/8fr/2w

<6weeks

Follow-up

Resection

Chemo

GEM 1000mg/m 2 day1,8,15(3w ）

within 10w